查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1463062

急性復發性癲癇市場、佔有率、規模、趨勢、產業分析報告：依產品、最終用途、地區和細分市場預測，2024-2032 年

Acute Repetitive Seizures Market Share, Size, Trends, Industry Analysis Report, By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel, Others); By End Use; By Region; And Segment Forecasts, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2032 年，全球急性復發性癲癇市場規模預計將達到 79.4 億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

市場成長背後的驅動力是臨床研究的增加、對新藥推出的日益關注以及對用於癲癇治療的鼻噴劑的需求不斷增長。 此外，越來越多的監管批准和正在開發的有前景的治療方法預計也將在預測期內推動急性復發性癲癇市場的發展。 在努力控制醫療保健成本的同時，各國政府正在積極努力，透過引入家庭醫療保健和診所等門診護理模式，最大限度地降低住院和現場治療的成本。

孤兒藥可望透過大規模商業化主導全球市場。 USL-261 和 VALTOCO 的孤兒藥資格表明定價可能會上漲。 此外，與其他給藥方法相比，對鼻腔給藥途徑的偏好也預計將有助於這兩種藥物的使用增加。 對安全且具有成本效益的藥物替代品的需求不斷增長，促使評估透過鼻噴霧劑鼻內給藥的安全性和有效性的臨床試驗激增。 此外，隨著FDA批准數量的不斷增加，創新藥物預計很快就會推出，為急性復發性癲癇市場提供新的成長機會。

歐洲的成長是由神經學研究和開發投資的增加以及癲癇藥物需求的增加所推動的。 此外，科學、治療和醫學方面的技術進步也可能促進這一增長。 同時，旨在提高生活品質、提高疾病意識和改善醫療設施的政府措施是推動該地區市場擴張的關鍵因素。

包括新興國家在內的世界各國政府正積極推動醫療改革，以因應不斷上漲的醫療費用。 這些改革的一個重要方面是透過引入診所和家庭醫療保健等門診護理模式來減少住院時間和現場治療費用。 這種方法背後的基本原理是使醫療保健服務更具成本效益、更方便且以患者為中心。 醫療改革可以提高治療的可近性，減輕醫院資源的壓力，並改善病患的治療結果。 隨著新興國家政府專注於實施此類改革，門診護理模式的成長預計將透過提供更有效率、更具成本效益的患者照護方式來推動市場擴張。

急性復發性癲癇市場報告重點

USL-261 將在 2023 年佔最大的市場佔有率，由於易於管理，使其成為治療包括 ARS 在內的急性發作群體的有吸引力的選擇

醫療保健和製藥行業預計在預測期內將以最快的複合年增長率增長，有利的監管政策和市場批准將促進創新療法的商業化並促進市場增長。

北美尤其是美國的監管環境有利於醫療保健產業的創新和市場拓展。 美國食品藥物管理局 (FDA) 等監管機構為 ARS 治療的開發和批准提供了明確的指導方針和途徑，促進了市場成長。

預計亞太地區在預測期內將以最快的複合年增長率成長。 對醫療基礎設施的關注和對癲癇的認識的提高是新興市場成長的有利條件。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第 4 章急性複發性癲癇全球市場洞察

  • 急性復發性癲癇市場 - 產業概況
  • 急性復發性癲癇市場動態
    • 推動者和機會
      • 神經系統疾病盛行率的上升預計將推動市場成長
      • 全世界癲癇發生率的增加直接導致了 ARS 盛行率的增加。
    • 抑制因素和課題
      • 專業診斷測試和監測設備的可用性有限
  • 杵分析
  • 急性復發性癲癇產業的趨勢
  • 價值鏈分析
  • 新冠肺炎 (COVID-19) 影響分析

第 5 章依產品劃分的世界市場

  • 主要發現
  • 簡介
  • USL-261
  • NRL-1
  • AZ-002
  • Diastat直腸凝膠
  • 其他

第 6 章以最終用途劃分的全球市場

  • 主要發現
  • 簡介
  • 生物技術
  • 醫療保健和製藥
  • 其他

第 7 章依地區劃分的世界市場

  • 主要發現
  • 簡介
    • 2019-2032 年急性復發性癲癇市場評估（依地區）
  • 急性復發性癲癇市場 - 北美
    • 北美：急性復發性癲癇市場，依最終用途劃分，2019-2032 年
    • 北美：急性復發性癲癇市場（依產品），2019-2032 年
    • 急性復發性癲癇市場 - 美國
    • 急性復發性癲癇市場 - 加拿大
  • 急性復發性癲癇市場 - 歐洲
    • 歐洲：2019-2032 年急性復發性癲癇市場（依最終用途）
    • 歐洲：急性復發性癲癇市場（依產品），2019-2032 年
    • 急性復發性癲癇市場 - 英國
    • 急性復發性癲癇市場 - 法國
    • 急性復發性癲癇市場 - 德國
    • 急性復發性癲癇市場 - 義大利
    • 急性復發性癲癇市場 - 西班牙
    • 急性復發性癲癇市場 - 荷蘭
    • 急性複發性癲癇市場 - 俄羅斯
  • 急性復發性癲癇市場 - 亞太地區
    • 亞太地區：急性復發性癲癇市場，依最終用途，2019-2032 年
    • 亞太地區：急性復發性癲癇市場（依產品），2019-2032 年
    • 急性復發性癲癇市場 - 中國
    • 急性復發性癲癇市場 - 印度
    • 急性復發性癲癇市場 - 馬來西亞
    • 急性復發性癲癇市場 - 日本
    • 急性復發性癲癇市場 - 印度尼西亞
    • 急性復發性癲癇市場 - 韓國
  • 急性復發性癲癇市場 - 中東和非洲
    • 中東和非洲：急性復發性癲癇市場（以最終用途），2019-2032 年
    • 中東和非洲：急性複發性癲癇市場（依產品），2019-2032 年
    • 急性復發性癲癇市場 - 沙烏地阿拉伯
    • 急性復發性癲癇市場 - 阿聯酋
    • 急性復發性癲癇市場 - 以色列
    • 急性復發性癲癇市場 - 南非
  • 急性復發性癲癇市場 - 拉丁美洲
    • 拉丁美洲：急性復發性癲癇市場，依最終用途劃分，2019-2032 年
    • 拉丁美洲：急性復發性癲癇市場（依產品），2019-2032 年
    • 急性復發性癲癇市場 - 墨西哥
    • 急性復發性癲癇市場 - 巴西
    • 急性復發性癲癇市場 - 阿根廷

第八章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 合作/協作/合約/出版物

第九章公司簡介

  • ALEXZA
  • Alexza Pharmaceuticals
  • Bausch Health Companies Inc.
  • Neurelis, Inc.
  • Pfizer Inc.
  • Sanofi
  • UCB S.A. Belgium
  • Valeant Pharmaceuticals North America LLC.
  • VERITON PHARMA
Product Code: PM4747

The global acute repetitive seizures market size is expected to reach USD 7.94 billion by 2032, according to a new study by Polaris Market Research. The report "Acute Repetitive Seizures Market Share, Size, Trends, Industry Analysis Report, By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel, Others); By End Use; By Region; And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growth of the market is driven by an increasing number of clinical studies, a heightened focus on the introduction of new medicines, and a growing demand for nasal sprays as a treatment for epilepsy. Moreover, the upswing in regulatory approvals and promising treatments in the pipeline is anticipated to fuel the development of the acute repetitive seizures market over the projected period. In tandem with initiatives to curtail healthcare expenditure, governments are actively engaged in minimizing hospital stays and on-site treatment costs through the implementation of outpatient care models, including home healthcare and clinics.

Orphan drugs are anticipated to dominate the global market, driven by extensive commercialization. The designation of both USL-261 and VALTOCO as orphan drugs suggests that their pricing is likely to be elevated. Furthermore, the preference for the nasal route of administration over other methods is expected to contribute to the increased utilization of these two medications. The rising demand for safe and cost-effective alternatives has led to a surge in clinical trials assessing the safety and efficacy of nasal route administration through nasal sprays. Additionally, the increasing number of FDA approvals is expected to pave the way for the introduction of innovative medications soon, presenting new growth opportunities for the acute repetitive seizures market.

Europe's growth is attributed to heightened investment in neurology research and development, coupled with an increasing demand for epilepsy drugs. Additionally, advancements in technology within the scientific, therapeutic, and medical sectors are poised to contribute to this growth. Concurrently, government initiatives aimed at enhancing quality of life, raising awareness about the disease, and fostering improved healthcare facilities are the key drivers propelling market expansion in the region.

Governments worldwide, including emerging economies, are actively pursuing healthcare reforms to address rising healthcare costs. One significant aspect of these reforms involves reducing hospital stays and on-site treatment costs through the implementation of outpatient care models, such as clinics and home healthcare. The rationale behind this approach is to make healthcare services more cost-effective, accessible, and patient-centric. Healthcare reforms can lead to increased accessibility to treatment, reduced burdens on hospital resources, and improved patient outcomes. As governments in emerging economies focus on implementing such reforms, the growth of outpatient care models is expected to propel the expansion of the market by providing more efficient and cost-effective avenues for patient care.

Acute Repetitive Seizures Market Report Highlights

USL-261 segment held the largest market share in 2023, the convenience of administration makes USL-261 an attractive option for managing acute seizure clusters, including those characteristics of ARS

Healthcare & pharmaceuticals segment is expected to grow at the fastest CAGR during the forecast period, Favorable regulatory policies and market approvals facilitate the commercialization of innovative treatments, contributing to market growth.

North America region held the largest market share in 2023, The regulatory environment in North America, particularly in the United States, is conducive to innovation and market expansion in the healthcare sector. Regulatory agencies such as the Food and Drug Administration (FDA) provide clear guidelines and pathways for the development and approval of ARS treatments, facilitating market growth.

Asia Pacific is expected to grow at the fastest CAGR during the forecast period. The increased focus on healthcare infrastructure and rising awareness about epilepsy contribute to the favorable conditions for market growth in these developing nations.

The global players include ALEXZA, Alexza Pharmaceuticals, Bausch Health Companies Inc., Neurelis, Inc., Pfizer Inc., Sanofi, UCB S.A. Belgium, Valeant Pharmaceuticals North America LLC., VERITON PHARMA.

Acute Repetitive Seizures Market Research has segmented the acute repetitive seizures market report based on product, end use, and region:

Acute Repetitive Seizures, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • USL-261
  • NRL-1
  • AZ-002
  • Diastat Rectal Gel
  • Others

Acute Repetitive Seizures, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Biotechnology
  • Healthcare & pharmaceuticals
  • Others

Acute Repetitive Seizures, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LA
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Acute Repetitive Seizures Market Insights

  • 4.1. Acute Repetitive Seizures Market - Industry Snapshot
  • 4.2. Acute Repetitive Seizures Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Neurological Disorders is projected to spur the market growth
      • 4.2.1.2. The rising incidence of epilepsy cases worldwide directly contributes to the increasing prevalence of ARS
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited availability of specialized diagnostic tests or monitoring devices
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Acute Repetitive Seizures Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Acute Repetitive Seizures Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Acute Repetitive Seizures, by Product, 2019-2032 (USD Billion)
  • 5.3. USL-261
    • 5.3.1. Global Acute Repetitive Seizures Market, by USL-261, by Region, 2019-2032 (USD Billion)
  • 5.4. NRL-1
    • 5.4.1. Global Acute Repetitive Seizures Market, by NRL-1, by Region, 2019-2032 (USD Billion)
  • 5.5. AZ-002
    • 5.5.1. Global Acute Repetitive Seizures Market, by AZ-002, by Region, 2019-2032 (USD Billion)
  • 5.6. Diastat Rectal Gel
    • 5.6.1. Global Acute Repetitive Seizures Market, by Diastat Rectal Gel, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Acute Repetitive Seizures Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Acute Repetitive Seizures Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • 6.3. Biotechnology
    • 6.3.1. Global Acute Repetitive Seizures Market, by Biotechnology, by Region, 2019-2032 (USD Billion)
  • 6.4. Healthcare & pharmaceuticals
    • 6.4.1. Global Acute Repetitive Seizures Market, by Healthcare & pharmaceuticals, by Region, 2019-2032 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Acute Repetitive Seizures Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Acute Repetitive Seizures Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Acute Repetitive Seizures Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Acute Repetitive Seizures Market - North America
    • 7.3.1. North America: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
    • 7.3.2. North America: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.3.3. Acute Repetitive Seizures Market - U.S.
      • 7.3.3.1. U.S.: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.3.4. Acute Repetitive Seizures Market - Canada
      • 7.3.4.1. Canada: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • 7.4. Acute Repetitive Seizures Market - Europe
    • 7.4.1. Europe: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.3. Acute Repetitive Seizures Market - UK
      • 7.4.3.1. UK: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.4. Acute Repetitive Seizures Market - France
      • 7.4.4.1. France: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.5. Acute Repetitive Seizures Market - Germany
      • 7.4.5.1. Germany: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.6. Acute Repetitive Seizures Market - Italy
      • 7.4.6.1. Italy: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.7. Acute Repetitive Seizures Market - Spain
      • 7.4.7.1. Spain: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.8. Acute Repetitive Seizures Market - Netherlands
      • 7.4.8.1. Netherlands: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.9. Acute Repetitive Seizures Market - Russia
      • 7.4.9.1. Russia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • 7.5. Acute Repetitive Seizures Market - Asia Pacific
    • 7.5.1. Asia Pacific: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.5.3. Acute Repetitive Seizures Market - China
      • 7.5.3.1. China: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.5.4. Acute Repetitive Seizures Market - India
      • 7.5.4.1. India: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.5.5. Acute Repetitive Seizures Market - Malaysia
      • 7.5.5.1. Malaysia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.5.6. Acute Repetitive Seizures Market - Japan
      • 7.5.6.1. Japan: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.5.7. Acute Repetitive Seizures Market - Indonesia
      • 7.5.7.1. Indonesia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.5.8. Acute Repetitive Seizures Market - South Korea
      • 7.5.8.1. South Korea: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • 7.6. Acute Repetitive Seizures Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.6.3. Acute Repetitive Seizures Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.6.4. Acute Repetitive Seizures Market - UAE
      • 7.6.4.1. UAE: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.6.5. Acute Repetitive Seizures Market - Israel
      • 7.6.5.1. Israel: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.6.6. Acute Repetitive Seizures Market - South Africa
      • 7.6.6.1. South Africa: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • 7.7. Acute Repetitive Seizures Market - Latin America
    • 7.7.1. Latin America: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.7.3. Acute Repetitive Seizures Market - Mexico
      • 7.7.3.1. Mexico: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.7.4. Acute Repetitive Seizures Market - Brazil
      • 7.7.4.1. Brazil: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.7.5. Acute Repetitive Seizures Market - Argentina
      • 7.7.5.1. Argentina: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. ALEXZA
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Alexza Pharmaceuticals
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Bausch Health Companies Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Neurelis, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Pfizer Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Sanofi
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. UCB S.A. Belgium
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Valeant Pharmaceuticals North America LLC.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. VERITON PHARMA
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development

List of Tables

  • Table 1 Global Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 2 Global Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Acute Repetitive Seizures Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 5 North America: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 6 U.S.: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 7 U.S.: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 8 Canada: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 9 Canada: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 10 Europe: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 11 Europe: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 12 UK: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 13 UK: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 14 France: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 15 France: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Germany: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 17 Germany: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 18 Italy: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 19 Italy: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 20 Spain: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 21 Spain: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Russia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 25 Russia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 28 China: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 29 China: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 30 India: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 31 India: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Japan: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 Japan: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 38 South Korea: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 39 South Korea: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 44 UAE: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 45 UAE: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 46 Israel: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 47 Israel: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 48 South Africa: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 49 South Africa: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 50 Latin America: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 51 Latin America: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Mexico: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 53 Mexico: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Brazil: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 55 Brazil: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 56 Argentina: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 57 Argentina: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Acute Repetitive Seizures Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End Use
  • Figure 7 Global Acute Repetitive Seizures Market, by End Use, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Product
  • Figure 9 Global Acute Repetitive Seizures Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10 Acute Repetitive Seizures Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Acute Repetitive Seizures Market